The IQVIA Podcast
The pace of change in healthcare is accelerating. Our understanding of how data, technology and scientific expertise can come together is only getting more precise. In this podcast, leaders from IQVIA lead discussions on the issues, innovations, and collaborations that are making an impact on health and business outcomes. Topics will include new approaches to clinical development, leading-edge technologies and methodologies that extract more value (and less work) from healthcare data, and strategies that ensure the right medicines get to the right patients, faster. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward.
Podcasting since 2015 • 134 episodes
The IQVIA Podcast
Latest Episodes
Special Episode | Recording with BioSpace: AI’s Role in Decoding the FDA’s New Regulatory Communications
In this episode, BioSpace’s head of insights Lori Ellis discusses how AI transformation can help organizations navigate a rapidly evolving regulatory environment with senior director of regulatory innovation and technology, Michelle Gyzen.
•
15:44
Special Episode | Recording with BioSpace: Understanding the FDA’s AI Guidance in Pharmacovigilance
In this episode, BioSpace’s head of insights Lori Ellis discusses the FDA’s first draft guidance for AI in drug development, published in January 2025, with Archana Hegde, Senior Director, PV systems and innovations at IQVIA.
•
25:05
Special Episode | Recording with BioSpace: AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace
In this episode, BioSpace’s head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with Ana Pedro Jesuíno, global head local QPPV network at IQVIA.
•
13:42
Special Episode | Recording with BioSpace: We Don’t Own Patient Data–We’re Just Babysitting It
In this episode, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.
•
23:32